CLINICAL CASE OF ENCEPHALITISM WITH ANTIBODIES TO NMDA-RECEPTORS ON A NEW CORONAVIRUS INVESTIGATION (COVID-19)
During the outbreak of coronavirus disease 2019 (COVID-19) clinicians are increasingly involved in the observation of possible neurological complications due to the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Accumulating evidence indicates that COVID-19 patients commonly develop neurological symptoms. Some cases of encephalitis following the COVID-19 pandemic have been reported in literature that can mean possible damage to the central nervous system related to the SARS-CoV-2 infection. Early on, this was thought to be due to the direct effects of the virus itself, but the possibility of immune system mechanisms being implicated was gradually raised in the scientific literature. The reports of anti-NMDA receptor encephalitis among patients with COVID-19 at different ages may be signs of this condition. We report the case of a 16-year teenager concomitant Anti-N-Methyl-D-Aspartate Receptor (Anti-NMDAR) encephalitis and COVID-19. This clinical case brings argument on the possible relationship between SARS-CoV-2 infection and autoimmune encephalitis.